Developing digital therapeutics with KYAN Technologies' Prof. Dean Ho
Listen now
Description
Prof. Dean Ho is the Provost’s Chair Professor and Head of the Department of Biomedical Engineering at the National University of Singapore. He is also the Director of the Institute for Digital Medicine (WisDM) and The N.1 Institute for Health, and one of the Scientific Co-Founders of KYAN Technologies. In this episode, Prof. Ho discusses the importance of accessibility and community in fostering innovation. He highlights the role of academia in bridging the gap between innovation and real-world impact. Prof. Ho also shares his experience in setting up a biotech company in both the US and Singapore, emphasizing the ease and agility of the Singaporean ecosystem. He discusses the opportunities for AI in healthcare, particularly in clinical trial design and digital therapeutics. Prof. Ho also mentions the importance of a human talent pipeline to support the growing biotech industry in Singapore. Host: John Joson Ng Editors: Jessie Wong, John Joson Ng The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected].
More Episodes
Dr. Robert Ang is the CEO of Vor Biopharma, a clinical-stage cell and genome engineering therapy company. In this episode, Dr. Ang discusses the challenges of treating cancer, particularly acute myeloid leukemia (AML), and the need for new and innovative approaches. The conversation delves into...
Published 05/15/24
Published 05/15/24
Dr. Guy Heathers is the Chief Business Officer and one of the co-founders of Albatroz Therapeutics. In this episode, Dr. Guy Heathers shares his insights and experiences in the biotech industry, focusing on the challenges and opportunities faced by startups in Singapore. He discusses the...
Published 04/22/24